Caas Capital Management LP Bio N Tech Se Transaction History
Caas Capital Management LP
- $1.31 Billion
- Q1 2024
A detailed history of Caas Capital Management LP transactions in Bio N Tech Se stock. As of the latest transaction made, Caas Capital Management LP holds 8,163 shares of BNTX stock, worth $642,917. This represents 0.06% of its overall portfolio holdings.
Number of Shares
8,163
Previous 3,000
172.1%
Holding current value
$642,917
Previous $316,000
138.29%
% of portfolio
0.06%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding BNTX
# of Institutions
326Shares Held
40.4MCall Options Held
1.31MPut Options Held
1.37M-
Baillie Gifford & CO8.36MShares$658 Million0.61% of portfolio
-
Primecap Management CO Pasadena, CA4.81MShares$379 Million0.34% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.82MShares$301 Million2.24% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M3.47MShares$273 Million1.4% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U03.43MShares$270 Million1.76% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $19.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...